These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 23262982)
41. Epicardium and myocardium separate from a common precursor pool by crosstalk between bone morphogenetic protein- and fibroblast growth factor-signaling pathways. van Wijk B; van den Berg G; Abu-Issa R; Barnett P; van der Velden S; Schmidt M; Ruijter JM; Kirby ML; Moorman AF; van den Hoff MJ Circ Res; 2009 Aug; 105(5):431-41. PubMed ID: 19628790 [TBL] [Abstract][Full Text] [Related]
42. Fucoidan promotes osteoblast differentiation via JNK- and ERK-dependent BMP2-Smad 1/5/8 signaling in human mesenchymal stem cells. Kim BS; Kang HJ; Park JY; Lee J Exp Mol Med; 2015 Jan; 47(1):e128. PubMed ID: 25572360 [TBL] [Abstract][Full Text] [Related]
43. ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a. Wen-Sheng W Oncogene; 2003 Feb; 22(7):955-63. PubMed ID: 12592382 [TBL] [Abstract][Full Text] [Related]
44. Desipramine-induced Ca-independent apoptosis in Mg63 human osteosarcoma cells: dependence on P38 mitogen-activated protein kinase-regulated activation of caspase 3. Lu T; Huang CC; Lu YC; Lin KL; Liu SI; Wang BW; Chang PM; Chen IS; Chen SS; Tsai JY; Chou CT; Jan CR Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):297-303. PubMed ID: 18986328 [TBL] [Abstract][Full Text] [Related]
45. Nav1.7-Ca2+ influx-induced increased phosphorylations of extracellular signal-regulated kinase (ERK) and p38 attenuate tau phosphorylation via glycogen synthase kinase-3beta: priming of Nav1.7 gating by ERK and p38. Nemoto T; Miyazaki S; Kanai T; Maruta T; Satoh S; Yoshikawa N; Yanagita T; Wada A Eur J Pharmacol; 2010 Aug; 640(1-3):20-8. PubMed ID: 20470771 [TBL] [Abstract][Full Text] [Related]
46. Inhibition of ERK and activation of p38 are involved in diallyl disulfide induced apoptosis of leukemia HL-60 cells. Tan H; Ling H; He J; Yi L; Zhou J; Lin M; Su Q Arch Pharm Res; 2008 Jun; 31(6):786-93. PubMed ID: 18563362 [TBL] [Abstract][Full Text] [Related]
48. TGF-β inhibits osteogenesis by upregulating the expression of ubiquitin ligase SMURF1 via MAPK-ERK signaling. Sun X; Xie Z; Ma Y; Pan X; Wang J; Chen Z; Shi P J Cell Physiol; 2018 Jan; 233(1):596-606. PubMed ID: 28322449 [TBL] [Abstract][Full Text] [Related]
49. Ugonin K promotes osteoblastic differentiation and mineralization by activation of p38 MAPK- and ERK-mediated expression of Runx2 and osterix. Lee CH; Huang YL; Liao JF; Chiou WF Eur J Pharmacol; 2011 Oct; 668(3):383-9. PubMed ID: 21806985 [TBL] [Abstract][Full Text] [Related]
50. Role of MAP kinase pathways in mediating IL-6 production in human primary mesangial and proximal tubular cells. Leonard M; Ryan MP; Watson AJ; Schramek H; Healy E Kidney Int; 1999 Oct; 56(4):1366-77. PubMed ID: 10504489 [TBL] [Abstract][Full Text] [Related]
51. Geraniin inhibits migration and invasion of human osteosarcoma cancer cells through regulation of PI3K/Akt and ERK1/2 signaling pathways. Wang Y; Wan D; Zhou R; Zhong W; Lu S; Chai Y Anticancer Drugs; 2017 Oct; 28(9):959-966. PubMed ID: 28704237 [TBL] [Abstract][Full Text] [Related]
52. Astragaloside II induces osteogenic activities of osteoblasts through the bone morphogenetic protein-2/MAPK and Smad1/5/8 pathways. Kong XH; Niu YB; Song XM; Zhao DD; Wang J; Wu XL; Zhang R; Mei QB Int J Mol Med; 2012 Jun; 29(6):1090-8. PubMed ID: 22426655 [TBL] [Abstract][Full Text] [Related]
53. Cross-talk between bone morphogenetic protein 2 and leukemia inhibitory factor through ERK 1/2 and Smad1 in protection against doxorubicin-induced injury of cardiomyocytes. Izumi M; Masaki M; Hiramoto Y; Sugiyama S; Kuroda T; Terai K; Hori M; Kawase I; Hirota H J Mol Cell Cardiol; 2006 Feb; 40(2):224-33. PubMed ID: 16427075 [TBL] [Abstract][Full Text] [Related]
54. Mitogen-activated protein kinase mediates mevalonate-stimulated human mesangial cell proliferation. Zhou X; Wang C; Tian J; Wang Y; Li Y; Hu Z; Li R Mol Med Rep; 2015 Aug; 12(2):2643-9. PubMed ID: 25936991 [TBL] [Abstract][Full Text] [Related]
55. Bone morphogenetic protein-9 activates Smad and ERK pathways and supports human osteoclast function and survival in vitro. Fong D; Bisson M; Laberge G; McManus S; Grenier G; Faucheux N; Roux S Cell Signal; 2013 Apr; 25(4):717-28. PubMed ID: 23313128 [TBL] [Abstract][Full Text] [Related]
56. Crosstalk between tyrosine kinase receptors, GSK3 and BMP2 signaling during osteoblastic differentiation of human mesenchymal stem cells. Biver E; Thouverey C; Magne D; Caverzasio J Mol Cell Endocrinol; 2014 Jan; 382(1):120-130. PubMed ID: 24060635 [TBL] [Abstract][Full Text] [Related]
57. Effects of vascular endothelial cells on osteogenic differentiation of noncontact co-cultured periodontal ligament stem cells under hypoxia. Wu Y; Cao H; Yang Y; Zhou Y; Gu Y; Zhao X; Zhang Y; Zhao Z; Zhang L; Yin J J Periodontal Res; 2013 Feb; 48(1):52-65. PubMed ID: 22905750 [TBL] [Abstract][Full Text] [Related]
58. Myricetin induces human osteoblast differentiation through bone morphogenetic protein-2/p38 mitogen-activated protein kinase pathway. Hsu YL; Chang JK; Tsai CH; Chien TT; Kuo PL Biochem Pharmacol; 2007 Feb; 73(4):504-14. PubMed ID: 17113042 [TBL] [Abstract][Full Text] [Related]
59. Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension. Yang X; Long L; Southwood M; Rudarakanchana N; Upton PD; Jeffery TK; Atkinson C; Chen H; Trembath RC; Morrell NW Circ Res; 2005 May; 96(10):1053-63. PubMed ID: 15845886 [TBL] [Abstract][Full Text] [Related]
60. NELL-1-dependent mineralisation of Saos-2 human osteosarcoma cells is mediated via c-Jun N-terminal kinase pathway activation. Chen F; Walder B; James AW; Soofer DE; Soo C; Ting K; Zhang X Int Orthop; 2012 Oct; 36(10):2181-7. PubMed ID: 22797704 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]